Conversely, IFN-γ production by infiltrating CD8+ T cells has been shown to upregulate PD-L1, indoleamine 2,3-dioxygenase (IDO) and Tregs in the tumor microenvironment [49,50], contributing to impair T cell responses and dampening vaccine efficacy [51]. The gene discussed is IFNG; the disease is neoplasm.